---
title: "Vula Medical Founder Joins 2026 Reckitt Catalyst Cohort"
description: "Vula Medical says Dr William Mapham has joined the 2026 Reckitt Catalyst cohort, a global programme that supports health and hygiene entrepreneurs."
canonical_url: "https://liners.com/news/vula-medical-william-mapham-reckitt-catalyst-2026"
markdown_url: "https://liners.com/news/vula-medical-william-mapham-reckitt-catalyst-2026.md"
type: "article"
language: "en"
published_at: "2026-10-21T19:36:46.412Z"
updated_at: "2026-10-21T19:36:52.204Z"
---

# Vula Medical Founder Joins 2026 Reckitt Catalyst Cohort

Vula Medical says Dr William Mapham has joined the 2026 Reckitt Catalyst cohort, a global programme that supports health and hygiene entrepreneurs.

## Breadcrumbs

- [News](/news)
- [Vula Medical Founder Joins 2026 Reckitt Catalyst Cohort](/news/vula-medical-william-mapham-reckitt-catalyst-2026)

## Content

## In Short
Vula Medical has announced that its founder, Dr William Mapham, has joined the 2026 Reckitt Catalyst cohort.

## What Happened
[Vula Medical](/vula-medical) shared the update on its Stories page, dated October 20, 2026.

The Reckitt Catalyst cohort is a support programme for founders building products in health, hygiene, and related areas. Cohorts usually combine mentoring, expert help, and connections to partners, rather than acting like a traditional funding round.

Vula Medical is a digital referral platform. In simple terms, it helps health workers send a patient case to the right specialist or facility using a structured digital workflow, instead of relying on phone calls, paper notes, or informal messaging.

On the same Stories page, Vula Medical highlights scale metrics for its referral network. These include over 3 million patient referrals sent, 70+ specialties covered, 2,500+ public and private facilities, and 44,000+ health professionals on the platform.

## Why It Matters
For African health tech, programmes like Reckitt Catalyst can help founders translate product traction into stronger partnerships with health systems, insurers, and suppliers.

For Vula Medical specifically, the recognition signals continued interest in tools that improve referral pathways, meaning the steps a patient takes from primary care to specialist care. Better referral pathways can reduce delays, improve decision-making, and help public and private providers collaborate more consistently.

If the cohort support leads to more integrations and clearer rollout playbooks, it could also help Vula Medical expand usage across more facilities and clinical specialties without adding heavy operational overhead.

## Sources and products

- [vulamedical.com](https://www.vulamedical.com/stories)
- [Vula Medical](/vula-medical)

## Related pages

- [People & Leadership](/news)

## Access and citation

- [Canonical HTML page](https://liners.com/news/vula-medical-william-mapham-reckitt-catalyst-2026)
- [Markdown route index](/sitemap.md)
- [Agent access guide](/llms.txt)